Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, April 18, 2023
[ Tue, Apr 18th 2023
] - WOPRAI
[ Tue, Apr 18th 2023
] - WOPRAI
[ Tue, Apr 18th 2023
] - WOPRAI
[ Tue, Apr 18th 2023
] - WOPRAI
[ Tue, Apr 18th 2023
] - WOPRAI
[ Tue, Apr 18th 2023
] - WOPRAI
[ Tue, Apr 18th 2023
] - WOPRAI
[ Tue, Apr 18th 2023
] - WOPRAI
[ Tue, Apr 18th 2023
] - WOPRAI
[ Tue, Apr 18th 2023
] - WOPRAI
[ Tue, Apr 18th 2023
] - WOPRAI
[ Tue, Apr 18th 2023
] - WOPRAI
[ Tue, Apr 18th 2023
] - WOPRAI
[ Tue, Apr 18th 2023
] - WOPRAI
Mon, April 17, 2023
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
Tony Butler Maintained (ALLO) at Strong Buy and Held Target at $15 on, Apr 17th, 2023
Tony Butler of EF Hutton, Maintained "Allogene Therapeutics, Inc." (ALLO) at Strong Buy and Held Target at $15 on, Apr 17th, 2023.
Tony has made no other calls on ALLO in the last 4 months.
There are 8 other peers that have a rating on ALLO. Out of the 8 peers that are also analyzing ALLO, 2 agree with Tony's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- William Pickering of "Bernstein" Initiated at Hold and Held Target at $6 on, Tuesday, March 21st, 2023
- Benjamin Chaiken of "JMP Securities" Maintained at Hold with Decreased Target to $19 on, Thursday, March 2nd, 2023
These are the ratings of the 6 analyists that currently disagree with Tony
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $23 on, Tuesday, April 4th, 2023
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $31 on, Thursday, March 2nd, 2023
- Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $22 on, Wednesday, March 1st, 2023
- Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $28 on, Wednesday, March 1st, 2023
- Brian Cheng of "JP Morgan" Upgraded from Hold to Buy and Decreased Target to $11 on, Tuesday, January 24th, 2023
- Jack Allen of "Baird" Upgraded from Hold to Buy and Held Target at $12 on, Friday, January 6th, 2023
